助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[23]条 当前为第1条到20条
 

相关语句
chronic severe viral hepatitis
    Clinical Analysis of 56 Cases of Biopsy Proved Subacute and Chronic Severe Viral Hepatitis
    亚急性、慢性重型病毒性肝炎56例临床分析
    Ultrastructural observation on the neutrophils of patients with chronic severe viral hepatitis
    慢性重型病毒性肝炎中性粒细胞超微结构的初步观察
    Clinical Studies on Treatment of Chronic Severe Viral Hepatitis with PGE1
    PGE1治疗慢性重型病毒性肝炎的临床研究
    A Clinical Analysis on Chronic Severe Viral Hepatitis Complicated With Spontaneous Bacterial Peritonitis
    慢性重型病毒性肝炎并自发性细菌性腹膜炎的临床分析
    Conclusion Our studies suggested that PGE1 were effective for chronic severe viral hepatitis and corrected remarkedly pathological disturbance ,it can act as a effective drug in comprehensive treatment for chronic severe viral hepatitis.
    结果发现PGE1治疗有效患者血浆内毒素、TNFα、总胆红素(SB)水平下降,PGE2水平上升。 结论应用PGE1治疗慢性重型病毒性肝炎可部分缓解病情和纠正重型肝炎的病理障碍,故可作为慢性重型病毒性肝炎综合治疗的一种有效药物。
    Objective To investigate the influence of recombined human growth hormone(rHGH) on the growth hormone(GH) and insulin-like growth factor(GH-IGF) axes in the patients with chronic severe viral hepatitis(CSVH).
    目的研究重组人生长激素(rHGH)对慢性重型病毒性肝炎(chronic severe viral hepatitis,CSVH)患者生长激素(growth hormone,GH)-胰岛素样生长因子(insulin-like growth factor,GH-IGF)轴的变化以及其影响。
    Objective To analyze the acquirement of nutrient and the statement of malnutrition in patients with chronic severe viral hepatitis and to direct the nutritional evaluation and the nutritional support in treatment to enhance survival rate.
    目的比较分析慢性重型病毒性肝炎患者(慢重肝)与肝炎后肝硬化患者(肝硬化)入院时的膳食营养素摄入量和营养不良指标,以指导慢重肝的营养评价和营养支持,提高其存活率。
    A preliminary study on plasma and urinary LPO levels in patients with chronic severe viral hepatitis
    慢性重型病毒性肝炎患者血浆和尿液脂质过氧化物水平及其意义
    Electron microscopic observation on adhesive platelet in patients with chronic severe viral hepatitis
    慢性重型病毒性肝炎粘附血小板的电镜观察
    Effects of recombined human growth hormone on growth hormone and insulin-like growth factor axes in patients with chronic severe viral hepatitis
    重组人生长激素对慢性重型病毒性肝炎生长激素-胰岛素样生长因子轴的影响
    Effects of rhGH combined with lactuiose on the prognosis of chronic severe viral hepatitis
    重组人生长激素联合乳果糖治疗慢性重型病毒性肝炎的疗效分析
    Correlation between Interleukin-18 Expression and Severity in Patients with Chronic Severe Viral Hepatitis and Observation of N-Acetylcysteine on Therapeutic Effect
    IL-18与慢性重型病毒性肝炎的相关性及N-乙酰半胱氨酸疗效的研究
    Objectives To determine whether there is a correlation of serum interleukin-18 (IL-18) level with the severity of chronic severe viral hepatitis (CSVH) in the course of the disease evolution.
    目的:①探讨白细胞介素18(IL-18)等细胞因子在慢性重型病毒性肝炎(慢重肝)早期病变过程中的作用;
    Objective: To evaluate the clinical efficacy of ALSS for chronic severe viral hepatitis, and primarily investigate the effection of ALSS on HepG2 cell apoptosis.
    目的对各型非生物人工肝支持系统(NB-ALSS)治疗慢性重型病毒性肝炎(CSVH)的临床疗效进行比较,并初步研究其对肝细胞凋亡的影响。
    56 cases of biopsy proved subacute and chronic severe viral hepatitis are analysed. It showed that the serum bilirubin and the degree of prothrombin activity were important prognostic factors.
    本文对经组织学证实的亚急性及慢性重型病毒性肝炎56例进行了临床分析,发现患者血清胆红素及凝血酶原活动度为影响患者预后的重要指标。
    The plasma and urinary lipid peroxides (LPO)levels were measured by fluorometric assay in 38 patients with chronic severe viral hepatitis(CSVH), 22 patients with acute hepatitis (AH)and 20 healthy controls.
    采用荧光法检测38例慢性重型病毒性肝炎(慢重肝)、22例急性肝炎和20名正常人血浆和尿液脂质过氧化物(LPO)含量。
    Methods The hybrid artificial liver support system (HALSS) consisted of a bioreactor containing more than 5×109 porcine hepatocytes and plasma exchange device. 15 patients with chronic severe viral hepatitis were treated with the hybrid system.
    方法 应用内含5×10~9以上猪肝细胞的生物反应器结合血浆置换装置,构建混合型人工肝支持系统(HALSS),并用于治疗15例慢性重型病毒性肝炎患者。
    Methods:The hybrid artificial liver support system(HALSS) consists of a bioreactor containing of more than 5×10 9 porcine hepatocytes and plasma exchange device. 15 patients with chronic severe viral hepatitis were treated with the hybrid system.
    方法 :应用内含5× 10 9以上猪肝细胞的生物反应器结合血浆置换装置 ,构建混合型人工肝支持系统 (HALSS) ,用于治疗 15例慢性重型病毒性肝炎患者。
    Objective On the purpose of further estimation of therapeutic effects on chronic severe viral hepatitis with PGE1.Methods we observed the plasma levels of endotoxin,TNF-α,PGE2 and changes of other clinical features before and after PGE1 treatment for 31 patients of chronic sevre viral hepatitis with PGE1. Results The decreased plasma levels of endotoxin,TNF-α,SB,ALT and the increased plasma level of PGE2 ,PTa were achieved after treatment.
    目的为探讨PGE1治疗慢性重型病毒性肝炎的机理和价值。 方法本文观察了31例慢性重型病毒性肝炎患者PGE1治疗前后血浆内毒素、肿瘤坏死因子α(TNFα)、前列腺素E2(PGE2)水平及其他临床指标的变化。
    Objective Through review the clinical data of 28 patients with chronic severe viral hepatitis complicated with spontaneous bacterial peritonitis and 32 chronic severe viral hepatitis patients not complicated with spontaneous bacterial peritonitis,the results showed that the clinical manifestation of chronic severe viral hepatitis patients complicated with spontaneous bacterial peritonitis is not typical. There were high incidences of oral and pulmonary infections among the patients complicated with spontaneous bacterial peritonitis as compared with those without spontaneous peritonitis(P<0.01).
    通过对28例合并自发性细菌性腹膜炎的慢性重型病毒性肝炎患者和32例不合并自发性腹膜炎的慢性重型病毒性肝炎患者的临床资料进行分析,发现慢性重型病毒性肝炎患者合并自发性腹膜炎者临床表现不典型,出现口腔感染及肺部感染比例高于无腹膜炎的患者(P<0.01);
 

首页上一页12下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社